Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Gilead Sciences (NASDAQ:GILD) on Wednesday announced a collaboration with the Swiss non-profit The Global Fund to accelerate ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between with United ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Gilead Sciences, in partnership with the Global Fund, plans to supply a long-acting HIV prevention drug to low-income ...

A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

In the mid-nineties, a friend of mine told me that he lost 30 friends and acquaintances to HIV/AIDS in just one week. It was a miracle that he was still alive. Although cases have decreased ...

The results expose a striking prevalence of high-risk sexual behaviours. Over one-third of participants (34.0%) disclosed ...

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...

State's Health Outreach and Prevention program will end June 30 after federal funding cuts to HIV outreach and prevention ...